ArticleFrontiers in endocrinology2025
Comparison of clinical indicators between perimenopausal and postmenopausal women with cardiovascular disease.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Identification of risk factors for type 2 diabetes across age-based proxies of early and late postmenopausal stages in prediabetic women.Frontiers in endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cardiovascular disease (CVD) prevalence increases with age, particularly in perimenopausal and postmenopausal women due to declining estrogen levels increasing CVD risk. Methods and results: From 1248 women, 276 with CVD were screened. Clinical indicators (obesity, blood pressure, BMD, hormones) were compared between perimenopausal and postmenopausal women and across age groups (40-44, 45-49, 50-54). Postmenopausal women had significantly higher BMI, WC/HC, BFP, BFD, SBP, DBP, E2, P, PRL ( Conclusions: This study elucidates how hormonal changes affect CVD development in women, providing a basis for early screening and intervention strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.